Zacks Research Analysts Reduce Earnings Estimates for WST
West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) – Zacks Research decreased their Q2 2027 earnings estimates for shares of West Pharmaceutical Services in a research report issued to clients and investors on Thursday, March 5th. Zacks Research analyst Team now expects that the medical instruments supplier will earn $2.26 per share for the quarter, […]
11 Mar 06:20 · The Markets Daily